[go: up one dir, main page]

DK0707567T3 - Fremgangsmåde til syntese af azetidinoner - Google Patents

Fremgangsmåde til syntese af azetidinoner

Info

Publication number
DK0707567T3
DK0707567T3 DK94921407T DK94921407T DK0707567T3 DK 0707567 T3 DK0707567 T3 DK 0707567T3 DK 94921407 T DK94921407 T DK 94921407T DK 94921407 T DK94921407 T DK 94921407T DK 0707567 T3 DK0707567 T3 DK 0707567T3
Authority
DK
Denmark
Prior art keywords
substituted
pct
beta
amino
azetidinones
Prior art date
Application number
DK94921407T
Other languages
English (en)
Inventor
Chou-Hong Tann
Tiruvettipuram K Thiruvengadam
Timothy Mcallister
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22217215&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0707567(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0707567T3 publication Critical patent/DK0707567T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK94921407T 1993-07-09 1994-07-01 Fremgangsmåde til syntese af azetidinoner DK0707567T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8935793A 1993-07-09 1993-07-09
PCT/US1994/007291 WO1995001961A1 (en) 1993-07-09 1994-07-01 Process for the synthesis of azetidinones

Publications (1)

Publication Number Publication Date
DK0707567T3 true DK0707567T3 (da) 2001-11-26

Family

ID=22217215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94921407T DK0707567T3 (da) 1993-07-09 1994-07-01 Fremgangsmåde til syntese af azetidinoner

Country Status (21)

Country Link
US (1) US5728827A (da)
EP (1) EP0707567B1 (da)
JP (1) JP2840452B2 (da)
KR (1) KR0176001B1 (da)
CN (1) CN1071745C (da)
AT (1) ATE205475T1 (da)
AU (1) AU681419B2 (da)
CA (1) CA2166784C (da)
CZ (1) CZ7696A3 (da)
DE (1) DE69428280T2 (da)
DK (1) DK0707567T3 (da)
ES (1) ES2160125T3 (da)
FI (1) FI960095L (da)
HU (1) HUT73237A (da)
MX (1) MX9405152A (da)
NO (1) NO306294B1 (da)
NZ (1) NZ268798A (da)
PL (1) PL312502A1 (da)
PT (1) PT707567E (da)
SK (1) SK3796A3 (da)
WO (1) WO1995001961A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
AU2030100A (en) * 1998-12-07 2000-06-26 Schering Corporation Process for the synthesis of azetidinones
US6207822B1 (en) 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
AR023463A1 (es) * 1999-04-16 2002-09-04 Schering Corp Uso de compuestos de azetidinona
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US7417039B2 (en) 2001-01-26 2008-08-26 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
CN100509058C (zh) 2001-01-26 2009-07-08 先灵公司 过氧化物酶体增殖物激活受体(ppar)活化剂和甾醇吸收抑制剂的组合药以及对于血管适应症的治疗
SI1373230T1 (sl) * 2001-03-28 2005-12-31 Schering Corp Enantioselektivna sinteza azetidinonskih intermediatnih spojin
US7132415B2 (en) * 2001-09-21 2006-11-07 Schering Corporation Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030204096A1 (en) * 2002-03-25 2003-10-30 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) * 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
CA2504878A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
MXPA05009501A (es) * 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP5137228B2 (ja) 2003-03-07 2013-02-06 メルク・シャープ・アンド・ドーム・コーポレーション 高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用
WO2005062824A2 (en) * 2003-12-23 2005-07-14 Merck & Co., Inc. Anti-hypercholesterolemic compounds
US7871998B2 (en) 2003-12-23 2011-01-18 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
EP1723414A4 (en) * 2004-01-16 2008-03-26 Merck & Co Inc NPC1L1 (NPC3) AND METHOD FOR IDENTIFYING ITS LIGANDS
JP2007538042A (ja) * 2004-05-21 2007-12-27 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 1,4−ジフェニルアゼチジノン誘導体の製造方法
DE102004025071B4 (de) * 2004-05-21 2006-12-21 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
SG158132A1 (en) 2004-12-20 2010-01-29 Schering Corp Process for the synthesis of azetidinones
JP2008546784A (ja) * 2005-06-20 2008-12-25 シェーリング コーポレイション ヒスタミンh3アンタゴニストとして有用なピペリジン誘導体
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
EP1986489A2 (en) * 2006-02-24 2008-11-05 Schering Corporation Npc1l1 orthologues
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
EP2059241A1 (en) * 2006-09-05 2009-05-20 Schering Corporation Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
WO2008032338A2 (en) * 2006-09-11 2008-03-20 Manne Satyanarayana Reddy Improved process for the preparation of ezetimibe and its intermediates
EA017349B1 (ru) 2007-01-24 2012-11-30 Крка Способ получения эзетимиба и его производных
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN104803858B (zh) * 2014-01-23 2019-03-01 东莞东阳光科研发有限公司 一种制备四丁基氟化铵三水合物的方法
ES2986788T3 (es) 2020-02-07 2024-11-12 Gasherbrum Bio Inc Agonistas heterocíclicos de GLP-1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333268A1 (en) * 1988-03-18 1989-09-20 Merck & Co. Inc. Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
US4876365A (en) * 1988-12-05 1989-10-24 Schering Corporation Intermediate compounds for preparing penems and carbapenems
US4983597A (en) * 1989-08-31 1991-01-08 Merck & Co., Inc. Beta-lactams as anticholesterolemic agents
US5085473A (en) * 1990-10-09 1992-02-04 Yuhe Yang Air actuated car curtain device
MY131273A (en) * 1991-07-23 2007-07-31 Schering Corp Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof

Also Published As

Publication number Publication date
ES2160125T3 (es) 2001-11-01
DE69428280D1 (de) 2001-10-18
AU7214694A (en) 1995-02-06
FI960095A0 (fi) 1996-01-09
WO1995001961A1 (en) 1995-01-19
NO306294B1 (no) 1999-10-18
JPH08507085A (ja) 1996-07-30
CZ7696A3 (en) 1996-04-17
ATE205475T1 (de) 2001-09-15
MX9405152A (es) 1995-01-31
AU681419B2 (en) 1997-08-28
FI960095L (fi) 1996-01-09
DE69428280T2 (de) 2002-06-13
JP2840452B2 (ja) 1998-12-24
PL312502A1 (en) 1996-04-29
CA2166784A1 (en) 1995-01-19
NZ268798A (en) 1997-01-29
SK3796A3 (en) 1997-02-05
EP0707567B1 (en) 2001-09-12
HU9503748D0 (en) 1996-02-28
NO960083D0 (no) 1996-01-08
KR0176001B1 (ko) 1999-03-20
KR960703853A (ko) 1996-08-31
NO960083L (no) 1996-03-04
CN1071745C (zh) 2001-09-26
PT707567E (pt) 2002-01-30
US5728827A (en) 1998-03-17
HUT73237A (en) 1996-07-29
CN1126989A (zh) 1996-07-17
EP0707567A1 (en) 1996-04-24
CA2166784C (en) 2001-12-11

Similar Documents

Publication Publication Date Title
DK0707567T3 (da) Fremgangsmåde til syntese af azetidinoner
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
IL113141A0 (en) Intermediates for hypoglycemic hydroxyurea detivatives
PL318100A1 (en) 2-[(dihydro) pyrazolyl-3'-oxymethylene]anilides, method of obtaining them and their application
PT934325E (pt) Trisanidridos biciclicos de tetrafosfonato
ZA9811576B (en) Anilide derivative, production and use thereof.
DK0703788T3 (da) Stabiliseret phenylalaninammoniaklyase
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
DK0687260T3 (da) Fremgangsmåde til fremstillingen af 9-desoxotaxaner
YU78303A (sh) Postupak za dobijanje 1,3-supstituisanih indena i azapolicikličnih jedinjenja sa pripojenim arilom
DE69523622D1 (de) Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
NZ331875A (en) Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
NZ330451A (da)
HK1088325A1 (en) Process for the preparation of baccatin III derivatives
BG104243A (en) Method for the synthesis of quinoline derivatives
IL172973A (en) Process for the preparation of (4s, 5r) - n - boc - 2 - (2' 4 - dimethoxyphenyl) - 4 - isobutyl - 1 - oxazolidine - 5 - carboxylic acid
MX9604466A (es) Proceso de preparacion de 7-trialquilsilil-baccatina iii.
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
MX9701569A (es) Pirimidin(tio)onas substituidas.
TR199701298T1 (xx) Tetralinler.
MXPA04004980A (es) Antagonistas del receptor ccr-3.
YU37902A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3- benzazocini i njihova primena kao lekova